Study guide
9.3 Maternal Trauma: Primary/Secondary Survey, Placental Abruption & Fetomaternal Hemorrhage
C-OBE Obstetric Emergencies Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Maternal Assessment, Risk Stratification & Early Warning Systems
1.1 Pre-Existing Medical, Surgical & Obstetric Comorbidities in Emergency Risk Stratification 1.2 Dynamic Antepartum & Intrapartum Risk Assessment 1.3 Maternal Early Warning Systems (MEWS/MEWT) & Critical Triage Physical Assessment 1.4 Alliance for Innovation on Maternal Health (AIM) Safety Bundles & Emergency Readiness
2 Chapter 2: Obstetric Hemorrhage — Etiology, Assessment & Uterotonics
2.1 Postpartum Hemorrhage Etiology (4 T's) & Quantitative Blood Loss (QBL) 2.2 Uterotonic Pharmacology & Stepwise Administration Protocols 2.3 Tranexamic Acid (TXA) Protocols & Hemorrhage Timing
3 Chapter 3: Obstetric Hemorrhage — Mechanical Interventions, Placental Disorders & Transfusion
3.1 Intrauterine Tamponade Balloons, Compression Sutures & Surgical Hemostasis 3.2 Ectopic Pregnancy, Placenta Previa, Accreta Spectrum (PAS), Abruption & Vasa Previa 3.3 Obstetric DIC, Coagulopathy & Massive Transfusion Protocol (MTP)
4 Chapter 4: Hypertensive Disorders of Pregnancy & Preeclampsia with Severe Features
4.1 Classification & Spectrum of Hypertensive Disorders of Pregnancy 4.2 Preeclampsia with Severe Features: Pathophysiology & End-Organ Damage 4.3 Diagnostic Evaluation, Laboratory Triggers & Fetal Surveillance in Preeclampsia
5 Chapter 5: Hypertensive Crisis, Eclampsia & Magnesium Sulfate Therapy
5.1 Acute Severe Hypertension & First-Line Antihypertensive Protocols 5.2 Eclampsia Recognition, Seizure Management & Airway Protection 5.3 Magnesium Sulfate Neuroprotection/Seizure Prophylaxis Protocols, Monitoring & Toxicity Reversal 5.4 HELLP Syndrome & Hepatic Crisis Management
6 Chapter 6: Maternal Resuscitation, Cardiac Arrest & Perimortem Cesarean
6.1 Maternal ACLS Modifications & Cardiopulmonary Resuscitation Physiology 6.2 Etiologies of Maternal Arrest & Structured Emergency Response 6.3 Perimortem Cesarean Delivery (PMCD / Resuscitative Hysterotomy)
7 Chapter 7: Amniotic Fluid Embolism & Maternal Shock States
7.1 Amniotic Fluid Embolism (AFE): Pathophysiology & Clinical Presentation 7.2 A-OK Protocol, Hemodynamic Support & Critical Care in AFE 7.3 Maternal Shock States: Hemorrhagic, Distributive, Cardiogenic & Obstructive
8 Chapter 8: Acute Intrapartum Delivery Emergencies
8.1 Shoulder Dystocia: Recognition, Timing & Primary HELPERR Sequence 8.2 Advanced Shoulder Dystocia Maneuvers & Neonatal Brachial Plexus Injury Prevention 8.3 Umbilical Cord Prolapse Recognition & Emergent Decompression Protocols
9 Chapter 9: Uterine Inversion, Malpresentation & Obstetric Trauma
9.1 Acute Uterine Inversion: Recognition, Tocolysis & Manual/Surgical Reduction 9.2 Emergency Vaginal Breech Extraction & Head Entrapment Maneuvers 9.3 Maternal Trauma: Primary/Secondary Survey, Placental Abruption & Fetomaternal Hemorrhage
10 Chapter 10: Maternal Sepsis, Intraamniotic Infection & Severe Infections
10.1 Maternal Sepsis: Physiological Criteria, S.O.S. Score & omSOFA 10.2 The Maternal Sepsis Hour-1 Bundle & Fluid/Vasopressor Optimization 10.3 Intraamniotic Infection (Triple I / Chorioamnionitis) & Severe Endometritis 10.4 Severe Pyelonephritis, Maternal Pneumonia & Severe Peripartum Infections
11 Chapter 11: Endocrine, Cardiovascular, Respiratory & Neurologic Emergencies
11.1 Diabetic Ketoacidosis (DKA), Maternal Hypoglycemia & Endocrine Resuscitation in Pregnancy 11.2 Peripartum Cardiomyopathy (PPCM), Acute Heart Failure, Acute Coronary Syndromes & Maternal Arrhythmias 11.3 Status Asthmaticus, Pulmonary Edema & ARDS in Pregnancy 11.4 Status Epilepticus, Acute Stroke & Cerebral Venous Sinus Thrombosis (CVST)
12 Chapter 12: Thromboembolism, Hepatorenal Disorders & Toxicologic Emergencies
12.1 Venous Thromboembolism (DVT/PE) Diagnosis, Treatment & Peripartum Anticoagulation 12.2 Acute Fatty Liver of Pregnancy (AFLP / Swansea Criteria) & Acute Kidney Injury 12.3 Peripartum Substance Overdose, Opioid Toxicity & Naloxone Administration
13 Chapter 13: Obstetric Anesthesia Emergencies & Critical Complications
13.1 High Spinal / Total Spinal Anesthesia & Aspiration Pneumonitis 13.2 Local Anesthetic Systemic Toxicity (LAST) & 20% Lipid Emulsion Rescue Protocol 13.3 Post-Dural Puncture Headache (PDPH), Epidural Hematoma & Abscess 13.4 Malignant Hyperthermia in Obstetric Anesthesia & Dantrolene Protocol
14 Chapter 14: Professional Practice, Team Communication, Debriefing & Health Equity
14.1 Crisis Resource Management (CRM), TeamSTEPPS & Structured Communication 14.2 Multidisciplinary Emergency Debriefing, Morbidity & Mortality, and Systems Learning 14.3 Perinatal Racial/Ethnic Disparities, Implicit Bias Mitigation & Respectful Maternity Care 14.4 Legal, Ethical, Documentation & EMTALA Standards in Obstetric Emergencies
9.3 Maternal Trauma: Primary/Secondary Survey, Placental Abruption & Fetomaternal Hemorrhage
Key Takeaways Explain This Topic AI
In pregnant trauma resuscitation, maternal stabilization is the absolute priority and represents the single most effective intervention for fetal resuscitation; continuous manual Left Uterine Displacement (LUD) must be maintained for all gestations >=20 weeks to prevent aortocaval compression from reducing venous return and cardiac output.
Due to normal pregnancy hypervolemia (40% to 50% increase in blood volume), a pregnant patient can lose 1,200 to 1,500 mL (30% to 35%) of blood volume before manifesting classic tachycardia or hypotension; because compensatory splanchnic and uterine vasoconstriction shunts blood away from the uteroplacental unit, abnormal fetal heart rate patterns serve as the earliest and most sensitive indicator of maternal hypovolemia.
All viable pregnant patients (>=22 to 24 weeks) experiencing blunt abdominal trauma require a minimum of 4 to 6 hours of continuous electronic fetal monitoring (EFM) to detect occult placental abruption; monitoring must be extended to 24 hours if uterine tenderness, frequent contractions (>=4 to 6/hr), vaginal bleeding, or fetal heart rate decelerations develop, noting that ultrasound has a sensitivity of only 25% to 50% for diagnosing abruption.
All Rh-negative pregnant trauma patients must receive Rh immune globulin (standard 300 mcg dose neutralizes up to 30 mL of fetal whole blood or 15 mL of fetal RBCs), with quantitative Kleihauer-Betke (KB) acid elution testing or flow cytometry performed to calculate additional required vials in cases of massive fetomaternal hemorrhage.
Last updated: August 2026
Maternal Trauma: Primary/Secondary Survey, Placental Abruption & Fetomaternal Hemorrhage
Trauma complicates approximately 1 in 12 pregnancies and remains the leading non-obstetric cause of maternal mortality in the United States. Motor vehicle collisions (MVCs) account for nearly 50% of pregnancy-related trauma cases, followed by intimate partner violence (IPV / domestic assault, 20% to 30%), falls, burns, and penetrating injuries. The pregnant trauma patient presents a unique clinical challenge because resuscitation must address two physiologically interconnected individuals. The foundational principle of obstetric trauma care is unambiguous: Stabilize the mother first—maternal resuscitation is the most effective form of fetal resuscitation.
1. ATLS Primary Survey with Obstetric Modifications
Resuscitation follows standard Advanced Trauma Life Support (ATLS) protocols ( Airway, Breathing, Circulation, Disability, Exposure ), but with critical modifications tailored to pregnancy-specific anatomy and physiology: +---------------------------------------------------------------------------------------------------+
- | ATLS PRIMARY SURVEY OBSTETRIC MODIFICATIONS |
- | |
- | A — AIRWAY & CERVICAL SPINE: |
- | • Mucosal friability, hypervascularity, and laryngeal edema increase failed intubation risk. |
- | • Use smaller endotracheal tubes (6.0 to 7.0 mm cuffed) and video laryngoscopy. |
- | • High aspiration risk: Progesterone delays gastric emptying and relaxes lower esophageal |
- | sphincter; every pregnant trauma patient is considered to have a 'full stomach.' |
- | • Avoid nasal airways or blind nasotracheal intubation due to severe epistaxis risks. |
- | |
- | B — BREATHING & OXYGENATION: |
- | • Maternal oxygen consumption (VO2) increases by 20-30%, while Functional Residual Capacity |
- | (FRC) decreases by 20-30% due to 4 cm cephalad diaphragm displacement by the gravid uterus. |
- | • Apnea precipitates precipitous desaturation; administer high-flow 100% O2 to maintain maternal|
- | SpO2 >=95% (PaO2 >70 mmHg) to ensure adequate fetoplacental oxygen gradient. |
- | • NORMAL BLOOD GAS ALTERATION: Normal pregnancy is a state of chronic respiratory alkalosis |
- | (pH 7.40–7.45, PaCO2 28–32 mmHg, HCO3 18–22 mEq/L). A 'normal' adult PaCO2 of 40 mmHg reflects |
- | severe hypoventilation and respiratory acidosis in pregnancy! |
- | • Chest tube insertion: Place thoracostomy tube 1 to 2 intercostal spaces higher (3rd or 4th |
- | intercostal space anterior axillary line) to avoid transdiaphragmatic abdominal entry. |
- | |
- | C — CIRCULATION & HEMODYNAMICS: |
- | • CONTINUOUS MANUAL LEFT UTERINE DISPLACEMENT (LUD): For all gestations >=20 weeks (fundus at or |
- | above umbilicus), manual LUD is mandatory to relieve aortocaval compression. Supine positioning|
- | reduces cardiac output by 30% to 40% and reduces uterine perfusion by up to 60%! |
- | • Deceptive Vital Signs: Plasma volume increases by 40-50%. Parturients can lose 1,200 to |
- | 1,500 mL (30% to 35%) of blood volume before showing tachycardia or hypotension. |
- | • Fetal Heart Rate (FHR) is the 'Canary in the Coal Mine': Uterine vasoconstriction preserves |
- | maternal central pressure at the expense of placental flow. Fetal bradycardia, tachycardia, or|
- | late decelerations are the EARLIEST indicators of maternal occult hypovolemia. |
- | • Resuscitation: Rapid crystalloid + early 1:1:1 blood product transfusion (MTP). Avoid pure |
- | alpha-adrenergic vasopressors (e.g., phenylephrine) as initial therapy due to uterine spasm. |
- | |
- | D — DISABILITY & NEUROLOGICAL ASSESSMENT: |
- | • Calculate Glasgow Coma Scale (GCS). Evaluate for seizures: Differentiate traumatic brain injury|
- | from eclamptic seizures; administer IV Magnesium Sulfate if preeclampsia/eclampsia suspected. |
- | |
- | E — EXPOSURE & ENVIRONMENT: |
- | • Fully undress and inspect for seatbelt sign, ecchymoses, penetrating entry/exit wounds, and |
- | pelvic instability. Perform speculum exam for vaginal bleeding, amniotic pooling, or rupture. |
- | • Prevent maternal hypothermia with warm blankets and warmed IV fluids. |
- +---------------------------------------------------------------------------------------------------+
- 2. Traumatic Placental Abruption: Pathophysiology & Recognition
Placental abruption (abruptio placentae) occurs in 1% to 5% of minor injuries and up to 40% to 50% of major blunt decelerating traumas. It is the leading cause of traumatic fetal demise.
Biomechanical Pathophysiology
The elastic, flexible myometrial wall stretches and deforms upon impact or sudden deceleration (e.g., rapid deceleration in motor vehicle collisions). In contrast, the placenta is an inelastic, rigid, vascular organ with zero elasticity. The resulting shear strain forces tear the decidua basalis away from the myometrium, severing spiral arteries and forming a retroplacental hematoma that rapidly strips the remaining placenta. +---------------------------------------------------------------------------------------------------+
- | DIAGNOSTIC COMPARISON: OCCULT VS. OVERT ABRUPTION |
- | |
- | • CLINICAL HALLMARKS OF TRAUMATIC PLACENTAL ABRUPTION: |
- | 1. Uterine Tenderness & Rigidity: 'Board-like', hypertonic, painful uterus on palpation. |
- | 2. High-Frequency Contractions / Uterine Tachysystole: >=6 contractions per hour; irritable. |
- | 3. Vaginal Bleeding: Present in 80% (external abruption); ABSENT in 20% (concealed abruption, |
- | where blood is trapped entirely retroplacentally behind the fetal head/membranes). |
- | 4. Fetal Heart Rate Abnormalities: Loss of variability, recurrent late decelerations, |
- | sinusoidal pattern (fetal anemia/hemorrhage), profound bradycardia, or demise. |
- | 5. Consumptive Coagulopathy (DIC): Hypofibrinogenemia (<200 mg/dL), elevated D-dimer, elevated |
- | PT/INR, thrombocytopenia from massive release of placental tissue factor into circulation. |
- | |
- | • CRITICAL ULTRASOUND LIMITATION: |
- | - Ultrasound sensitivity for placental abruption in acute trauma is ONLY 25% TO 50%! |
- | - Acute retroplacental hemorrhage is isoechoic to the adjacent placenta and myometrium, making |
- | it frequently invisible on sonography. |
- | - CLINICAL RULE: A NORMAL ULTRASOUND NEVER RULES OUT PLACENTAL ABRUPTION! |
- +---------------------------------------------------------------------------------------------------+
- 3. Continuous Electronic Fetal Monitoring (EFM) Protocols
In all trauma patients with a viable fetus ( >=22 to 24 weeks of gestation ), continuous electronic fetal monitoring of the fetal heart rate and uterine tocodynamometry is the primary diagnostic modality for assessing both fetal well-being and occult uterine trauma.
Monitoring Duration Guidelines
Standard Minimum Monitoring (4 to 6 Hours):
Indicated for all viable pregnant patients experiencing blunt abdominal trauma, even with minor injury, normal initial vital signs, absence of pain, and absence of vaginal bleeding.
More than 90% of traumatic abruptions manifest within the first 4 to 6 hours after injury.
Extended Monitoring (24 Hours):
Mandatory if any of the following high-risk features develop during the initial 4–6 hour observation window:
Uterine Contractions: >=4 to 6 contractions per hour.
Uterine Tenderness or Abdominal Pain: Persistent focal or diffuse tenderness, guarding, or uterine hypertonus.
Fetal Heart Rate Abnormalities: Tachycardia (>160 bpm), bradycardia (<110 bpm), decreased/absent variability, or recurrent late/variable decelerations.
Vaginal Bleeding or suspected rupture of membranes (positive pooling, Nitrazine, or ferning).
High-Risk Injury Mechanism: High-speed MVC (>35 mph), vehicle rollover, passenger ejection, death of another vehicle occupant, pedestrian struck, direct high-impact abdominal blow, unbelted occupant.
Maternal Laboratory Abnormalities: Coagulopathy (fibrinogen <200 mg/dL), severe anemia, or positive Kleihauer-Betke test.
4. Fetomaternal Hemorrhage & Rh Immune Globulin Management
Fetomaternal hemorrhage (FMH)—the transplacental intravasation of fetal erythrocytes into the maternal circulation—occurs in up to 30% of pregnant trauma cases (a 4- to 5-fold increase over baseline deliveries). In Rh-negative parturients carrying an Rh-positive fetus, FMH causes maternal isoimmunization, leading to hemolytic disease of the fetus and newborn (HDFN) in subsequent pregnancies. Massive FMH can also cause fatal fetal exsanguination and hypovolemic shock.
Diagnostic Testing Modalities
Rosette Test (Qualitative Screen):
A qualitative agglutination test that detects small quantities of D-positive fetal cells in Rh-negative maternal blood.
Sensitive down to ~10 mL of fetal whole blood. If negative, standard Rh immune globulin dosing is sufficient. If positive, quantitative testing is required.
Kleihauer-Betke (KB) Acid Elution Test (Quantitative Gold Standard):
Differential acid resistance test: Maternal red cells contain adult hemoglobin (HbA), which is soluble in acid and elutes out, leaving pale "ghost cells." Fetal red cells contain fetal hemoglobin (HbF), which is resistant to acid elution and retains its stain, appearing bright pink under microscopy.
The laboratory counts 2,000 cells and reports the percentage of fetal cells.
Flow Cytometry (Quantitative Alternative):
Uses monoclonal antibodies against HbF or RhD antigen to rapidly and accurately quantify fetal cells. +---------------------------------------------------------------------------------------------------+
- | KLEIHAUER-BETKE (KB) CALCULATION & RHOGAM DOSING |
- | |
- | • STANDARD RH IMMUNE GLOBULIN (RhoGAM) COVERAGE: |
- | - One standard 300 mcg (1,500 IU) vial neutralizes up to: |
- | * 30 mL of fetal WHOLE BLOOD, OR |
- | * 15 mL of fetal PACKED RED BLOOD CELLS. |
- | |
- | • STEP-BY-STEP KB DOSING FORMULA: |
- | 1. Calculate Fetal Whole Blood Volume (mL): |
- | Fetal Whole Blood (mL) = (% Fetal Cells / 100) x Maternal Blood Volume |
- | [Assume standard maternal blood volume = 5,000 mL] |
- | Simplified Formula: Fetal Whole Blood (mL) = % Fetal Cells x 50 |
- | |
- | 2. Calculate Number of 300 mcg Vials Required: |
- | Number of Vials = Fetal Whole Blood (mL) / 30 mL |
- | |
- | 3. Apply Mandatory Rounding Safety Rule: |
- | • If the digit to the right of the decimal is <5: Round DOWN to nearest whole integer |
- | and ADD 1 safety vial. |
- | • If the digit to the right of the decimal is >=5: Round UP to nearest whole integer |
- | and ADD 1 safety vial. |
- | |
- | • CLINICAL CALCULATION EXAMPLE: |
- | - Laboratory reports KB test = 1.6% fetal cells. |
- | - Step 1: Fetal Whole Blood = 1.6 x 50 = 80 mL. |
- | - Step 2: Vials = 80 mL / 30 mL = 2.67 vials. |
- | - Step 3: Decimal is >=5 (0.67 >= 0.5) -> Round 2.67 up to 3 -> Add 1 safety vial = 4 VIALS |
- | (1,200 mcg total Rh immune globulin). |
- | |
- | • TIMING OF ADMINISTRATION: |
- | - Administer within 72 hours of traumatic event; still administer even if delayed >72 hours. |
- +---------------------------------------------------------------------------------------------------+
- 5. Diagnostic Imaging Safety & The Bedside FAST Exam
Fear of ionizing radiation must never delay or prevent necessary diagnostic imaging in the injured pregnant patient. Maternal diagnostic imaging takes absolute priority.
Radiation Dose Safety Thresholds
Fetal Radiation Threshold: Exposure to cumulative radiation doses <50 mGy (5 rads) is NOT associated with any increase in fetal anomalies, intellectual disability, growth restriction, or pregnancy loss at any gestational age.
Common Trauma Imaging Doses:
- Chest X-ray (2 views with abdominal shield): <0.001 mGy
- Head CT: <0.05 mGy (fetal exposure is negligible scatter)
- Chest CT / CT Angiography for PE: 0.1 to 0.2 mGy
- Abdominal & Pelvic Trauma CT (with intravenous contrast): 10 to 35 mGy (well below the 50 mGy safe threshold!)
Contrast Media: Intravenous iodinated CT contrast crosses the placenta but is non-teratogenic and safe in trauma. Gadolinium-based MRI contrast crosses the placenta, is excreted into amniotic fluid, and carries potential toxicity risks; gadolinium is avoided in pregnancy unless absolutely vital.
Focused Assessment with Sonography for Trauma (FAST)
FAST Window Anatomical Target Pregnancy Modification & Clinical Pearls
Right Upper Quadrant (Morison's Pouch) Hepatorenal space Primary free fluid detection site. The enlarged uterus displaces small bowel upward, causing free intraperitoneal blood to track reliably into Morison's pouch.
Left Upper Quadrant (Splenorenal Recess) Perisplenic space & diaphragm Evaluates for splenic rupture / subcapsular hematoma. Transducer placed more posterior/cephalad.
Subxiphoid / Cardiac Window Pericardial space Assesses for hemopericardium and cardiac tamponade. Heart displaced cephalad/laterally.
Suprapubic / Pelvic Window Rectouterine pouch (Pouch of Douglas) MODIFIED IN PREGNANCY: After 20 weeks, the gravid uterus fills the true pelvis. Angle transducer cephalad and posterior to the uterine fundus to image free fluid pooling in the cul-de-sac.
Thoracic / E-FAST Windows Pleural spaces Assesses for pneumothorax (loss of lung sliding) and hemothorax.